Doxycycline use for community-acquired pneumonia: Contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002)

Diagnostic Microbiology and Infectious Disease

Volumn 49, Issue 2, 2004, Pages 147-149

  Jones, Ronald N ^a,b   Sader, Helio S ^a   Fritsche, Thomas R ^a  

^a JMI LABORATORIES   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; DOXYCYCLINE; MACROLIDE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DRUG POTENCY; DRUG USE; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; STREPTOCOCCUS PNEUMONIA;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DOXYCYCLINE; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 2942592107     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2004.02.005     Document Type: Article

References (12)

1. Ailani R.K., Agastya G., Mukunda B.N., Shekar R. Doxycycline is a cost-effective therapy for hospitalized patients with community-acquired pneumonia. Arch Intern Med. 159:1999;266-270
2. Cunha B.A., Domenico P., Cunha C.B. Pharmacodynamics of doxycycline. Clin Microbiol Infect. 6:2000;265-282
3. Cunha B.A. Community-acquired pneumonia Diagnostic and therapeutic considerations. Med Clin North Am. 85:2001;43-77
4. Cunha B.A. Doxycycline for community-acquired pneumonia. Clin Infect Dis. 37:2003;870
5. Doern G.V., Heilmann K.P., Huynh H.K., Rhomberg P.R., Coffman S.L., Brueggemann A.B. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother. 45:2001;1721-1729
6. Johnson J.R. Doxycycline for the treatment of community-acquired pneumonia. Clin Infect Dis. 35:2002;632
7. Lederman E.R., Gleeson T.D., Driscoll T., Wallace M.R. Doxycycline sensitivity of Streptococcus pneumoniae isolates. Clin Infect Dis. 36:2003;1091
8. Mandell L.A., Bartlett J.G., Dowell S.F., File T.M. Jr, Musher D.M., Whitney C. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis. 37:2003;1405-1433
9. Martinez F.J., Lynch J.R. III, File T.M. Reply. Clin Infect Dis. 35:2002;632-633
10. National Committee for Clinical Laboratory Standards (2003a). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 6th ed. Document M7-A6. NCCLS, Wayne, PA
11. National Committee for Clinical Laboratory Standards (2003b). Performance standards for antimicrobial susceptibility testing, 13th information supplement. Document M100-S13. NCCLS, Wayne, PA
12. Pfaller MA, Ehrhardt AF, Jones RN (2001). Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: Microbiology from the medical office practice environment. Am J Med 111, 4S-12S